The Kaplan–Meier survival curves for CpGs that are significantly prognostic after adjusting for age, gender, tumor grade, and IDH1 mutation are presented in Figure 2(Ci–Civ) for DFS along with forest plot visualization of hazard ratios with 95% CI in Figure 2D. For cg07425555 (Figure 2Ci), the median DFS of high methylation (“Meth”) versus low methylation (“Unmeth”) was 72 (52–91) months versus 31 (21–40) months (p < 0.001). This evidence concerns the gene IDH1 and neoplasm.